Genomics

Dataset Information

0

Myelodysplastic cells in patients re-program mesenchymal stromal cells to establish a transplantable stem cell-niche disease unit.


ABSTRACT: Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with defects in hematopoietic stem/progenitor cells (HSPCs) and possibly the HSPC niche. Here we show that patient-derived mesenchymal stromal cells (MDS MSCs) display a disturbed differentiation program and are essential for the propagation of MDS-initiating lin-CD34+CD38- stem cells in orthotopic xenografts. Overproduction of niche factors such as N-Cadherin, IGFBP2, VEGFA and LIF is associated with the ability of MDS MSCs to enhance MDS expansion. These factors represent putative therapeutic targets to disrupt critical hematopoietic-stromal interactions in MDS. Finally, healthy MSCs adopt "MDS-MSC like" molecular features when exposed to hematopoietic MDS cells, indicative of an instructive remodeling of their microenvironment. This patient-derived xenograft model therefore provides functional and molecular evidence that MDS is a complex disease involving both the hematopoietic and stromal compartments. The resulting deregulated expression of niche factors may well also be a feature of other hematopoietic malignancies.

PROVIDER: EGAS00001000716 | EGA |

REPOSITORIES: EGA

Similar Datasets

2024-01-26 | PXD039866 | Pride
2022-04-25 | GSE198823 | GEO
2022-04-25 | GSE198649 | GEO
2014-10-15 | E-GEOD-61695 | biostudies-arrayexpress
2016-07-25 | E-GEOD-84754 | biostudies-arrayexpress
2020-02-17 | GSE128089 | GEO
2024-04-23 | GSE217056 | GEO
2024-04-23 | GSE217055 | GEO
2020-07-17 | PXD017372 | Pride
2023-04-14 | GSE227143 | GEO